To view this email as a web page, click here.

In this issue of Dermatology Times, we focus on calming the flare by discussing topics such as individualized biologic therapies and advances in atopic dermatitis treatments. Explore these and other topics in this month's issue.
 
Dermatology Times cover
Dermatology Times cover
Individualized Biologic Therapy
A new study advises selecting biologic therapies for psoriasis based on individual factors such as patients' comorbidities, preferences and clinical situation, as well as the advantages and disadvantages of particular biologic treatments.
 
Advances in atopic dermatitis raise bar for treatment
In this article, Dr. Peter A. Lio discusses how recent advances in atopic dermatitis have led to a new standard of care, which aims to keep patients clear safely and maximize improvements in quality of life.
 
Table: The payer report card
There are several factors to consider when deciding to keep or terminate a payer contract. Underperformance by a payer often offsets a better fee schedule. Here are five reasons to consider terminating or renegotiating an agreement.
 
Two-system procedure for clearing actinic keratoses
Study finds daylight photodynamic therapy with ablative fractional laser more effective than with microdermabrasion for treating actinic keratoses with large area field cancerization.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.